Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Cures 2.0 Likely To Push US FDA To Further Embrace Real-World Evidence
Dec 10 2021
•
By
Sarah Karlin-Smith
Cures 2.0 should nudge FDA to be more comfortable using real-world evidence • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Real-World Evidence
More from Clinical Trials